| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 FKBP15 MYH2 MYH4 MYH6 ANK1 ANK2 MYH13 MARK1 DISC1 CAPN2 KIF16B TOGARAM1 VPS16 BICD1 DST TIAM1 NDC80 ARHGEF10 NFKB1 CEP70 MYH15 KIF5B DMD MTUS2 | 4.76e-09 | 1099 | 118 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | microfilament motor activity | 8.86e-08 | 38 | 118 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.98e-07 | 118 | 118 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH4 MYH6 MYH13 KIF16B NAIP RFC1 MSH6 ATP6V1H MDN1 ATP2C2 MYH15 KIF5B | 1.60e-05 | 614 | 118 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | PTB domain binding | 1.03e-04 | 3 | 118 | 2 | GO:0051425 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 3.72e-04 | 24 | 118 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | actin filament binding | 4.05e-04 | 227 | 118 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.38e-04 | 230 | 118 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | actin binding | 5.55e-04 | 479 | 118 | 10 | GO:0003779 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | ANK1 ANK2 CNST PGRMC1 PREPL PALS1 ATP2C2 KIF5B GOLGA4 LARGE1 | 1.49e-05 | 324 | 116 | 10 | GO:0072659 |
| GeneOntologyBiologicalProcess | muscle contraction | 1.62e-05 | 400 | 116 | 11 | GO:0006936 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MARK1 DISC1 KIF16B TOGARAM1 APP NPHP4 AK7 BICD1 DST NDC80 ARHGEF10 CEP70 TMF1 CC2D2A KIF5B CFAP57 ESPL1 HYDIN | 2.50e-05 | 1058 | 116 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.55e-05 | 153 | 116 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle system process | MYH1 MYH2 MYH4 MYH6 ANK2 MYH13 DTNA TIAM1 SCN1A SCN3A DMD LARGE1 | 6.03e-05 | 547 | 116 | 12 | GO:0003012 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 7.51e-05 | 15 | 116 | 3 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.26e-05 | 127 | 116 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.33e-04 | 18 | 116 | 3 | GO:0033275 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | ANK1 ANK2 CNST PGRMC1 PREPL PALS1 ATP2C2 KIF5B GOLGA4 LARGE1 | 1.37e-04 | 422 | 116 | 10 | GO:1990778 |
| GeneOntologyBiologicalProcess | positive regulation of testosterone secretion | 1.87e-04 | 4 | 116 | 2 | GO:2000845 | |
| GeneOntologyBiologicalProcess | cilium assembly | TCHP DISC1 TOGARAM1 FNBP1L AK7 CIBAR1 CEP70 CC2D2A CFAP57 HYDIN | 2.06e-04 | 444 | 116 | 10 | GO:0060271 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MARK1 DISC1 TOGARAM1 AK7 BICD1 DST NDC80 ARHGEF10 CEP70 CC2D2A CFAP57 ESPL1 HYDIN | 2.07e-04 | 720 | 116 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | organelle assembly | STAM2 MYH6 TCHP DISC1 TOGARAM1 FNBP1L AK7 BICD1 MDN1 NDC80 ARHGEF10 CIBAR1 CEP70 TMF1 CC2D2A CFAP57 HYDIN | 2.09e-04 | 1138 | 116 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | AMPH ANK1 DISC1 CAPN2 INSR TOGARAM1 UFL1 FNBP1L APP NPHP4 BICD1 LIG4 TIAM1 FCGR2A ARHGEF10 KIF5B DMD ESPL1 GOLGA4 | 2.15e-04 | 1366 | 116 | 19 | GO:0051130 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.29e-04 | 217 | 116 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 2.42e-04 | 54 | 116 | 4 | GO:0008340 | |
| GeneOntologyBiologicalProcess | intracellular transport | TANC2 STAM2 ANK1 POLDIP3 HTATIP2 KIF16B VPS16 FNBP1L APP PREPL BICD1 DST MDN1 ZFYVE9 UPF2 FCGR2A NUP133 KIF5B RASSF9 LARGE1 | 2.42e-04 | 1496 | 116 | 20 | GO:0046907 |
| GeneOntologyBiologicalProcess | testosterone secretion | 3.10e-04 | 5 | 116 | 2 | GO:0035936 | |
| GeneOntologyBiologicalProcess | regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | 3.10e-04 | 5 | 116 | 2 | GO:1903381 | |
| GeneOntologyBiologicalProcess | regulation of testosterone secretion | 3.10e-04 | 5 | 116 | 2 | GO:2000843 | |
| GeneOntologyBiologicalProcess | cilium organization | TCHP DISC1 TOGARAM1 FNBP1L AK7 CIBAR1 CEP70 CC2D2A CFAP57 HYDIN | 3.59e-04 | 476 | 116 | 10 | GO:0044782 |
| GeneOntologyBiologicalProcess | axoneme assembly | 3.78e-04 | 109 | 116 | 5 | GO:0035082 | |
| GeneOntologyBiologicalProcess | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 4.63e-04 | 6 | 116 | 2 | GO:0036483 | |
| GeneOntologyBiologicalProcess | NMDA selective glutamate receptor signaling pathway | 4.63e-04 | 6 | 116 | 2 | GO:0098989 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 4.72e-04 | 493 | 116 | 10 | GO:0007018 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 4.84e-04 | 115 | 116 | 5 | GO:0097061 | |
| GeneOntologyCellularComponent | myosin filament | 4.86e-09 | 25 | 119 | 6 | GO:0032982 | |
| GeneOntologyCellularComponent | myofibril | CAB39 MYH1 MYH2 MYH4 MYH6 ANK1 ANK2 MYH13 DST SCN1A MYH15 DMD NBR1 | 5.51e-09 | 273 | 119 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | supramolecular fiber | CAB39 MYH1 MYH2 MYH4 MYH6 ANK1 ANK2 MYH13 TCHP DISC1 KIF16B TOGARAM1 OCM2 VPS16 BICD1 DST OCM TIAM1 SCN1A MYH15 KIF5B DMD NBR1 MTUS2 PRPH | 9.38e-09 | 1179 | 119 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | myosin II complex | 1.02e-08 | 28 | 119 | 6 | GO:0016460 | |
| GeneOntologyCellularComponent | supramolecular polymer | CAB39 MYH1 MYH2 MYH4 MYH6 ANK1 ANK2 MYH13 TCHP DISC1 KIF16B TOGARAM1 OCM2 VPS16 BICD1 DST OCM TIAM1 SCN1A MYH15 KIF5B DMD NBR1 MTUS2 PRPH | 1.07e-08 | 1187 | 119 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | contractile muscle fiber | CAB39 MYH1 MYH2 MYH4 MYH6 ANK1 ANK2 MYH13 DST SCN1A MYH15 DMD NBR1 | 1.13e-08 | 290 | 119 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | muscle myosin complex | 2.28e-08 | 16 | 119 | 5 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 4.33e-08 | 59 | 119 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | axon | TANC2 FKBP15 AMPH ANK1 DTNA DISC1 INSR VPS16 APP NCDN PALS1 DST TIAM1 SCN1A SCN3A KIF5B SLC2A13 DMD SLC9A6 PRPH | 1.43e-07 | 891 | 119 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | sarcomere | 1.87e-07 | 249 | 119 | 11 | GO:0030017 | |
| GeneOntologyCellularComponent | A band | 4.93e-07 | 52 | 119 | 6 | GO:0031672 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 FKBP15 MYH2 MYH4 MYH6 AMPH MYH13 CAPN2 OCM2 VPS16 DST OCM MYH15 MYH16 | 5.16e-06 | 576 | 119 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | Z disc | 2.54e-05 | 151 | 119 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 4.66e-05 | 166 | 119 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | cell body | DISC1 CAPN2 INSR NAIP VPS16 APP PGRMC1 NCDN PALS1 TIAM1 FCGR2A SCN1A SCN3A SLC2A13 DMD PRPH | 7.48e-05 | 929 | 119 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 MARK1 CAPN2 INSR NAIP VPS16 APP PGRMC1 NCDN PALS1 TIAM1 FCGR2A SCN1A SCN3A KIF5B DMD SLC9A6 PRPH | 1.99e-04 | 1228 | 119 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.01e-04 | 94 | 119 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | microtubule organizing center | TCHP DISC1 TOGARAM1 CCDC178 NPHP4 BICD1 ORC2 TIAM1 NDC80 ARHGEF10 CIBAR1 CEP70 KIF5B ESPL1 MTUS2 | 2.29e-04 | 919 | 119 | 15 | GO:0005815 |
| GeneOntologyCellularComponent | cell cortex | 2.76e-04 | 371 | 119 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | astrocyte projection | 3.78e-04 | 25 | 119 | 3 | GO:0097449 | |
| GeneOntologyCellularComponent | type III intermediate filament | 4.75e-04 | 6 | 119 | 2 | GO:0045098 | |
| GeneOntologyCellularComponent | cilium | TCHP DISC1 TOGARAM1 CCDC178 APP NPHP4 AK7 TIAM1 CIBAR1 CC2D2A KIF5B CFAP57 HYDIN PRPH | 5.91e-04 | 898 | 119 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | intercalated disc | 6.14e-04 | 68 | 119 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | M band | 7.20e-04 | 31 | 119 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | sarcolemma | 7.73e-04 | 190 | 119 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 7.80e-04 | 263 | 119 | 7 | GO:0045111 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 8.62e-04 | 129 | 119 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | distal axon | 8.67e-04 | 435 | 119 | 9 | GO:0150034 | |
| GeneOntologyCellularComponent | neuronal cell body | CAPN2 INSR NAIP VPS16 APP PGRMC1 NCDN PALS1 TIAM1 SCN1A SCN3A DMD PRPH | 9.46e-04 | 835 | 119 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | centrosome | TCHP DISC1 NPHP4 BICD1 ORC2 TIAM1 NDC80 ARHGEF10 CEP70 KIF5B ESPL1 MTUS2 | 1.48e-03 | 770 | 119 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | main axon | 1.68e-03 | 89 | 119 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | recycling endosome | 1.72e-03 | 222 | 119 | 6 | GO:0055037 | |
| GeneOntologyCellularComponent | early endosome | 1.74e-03 | 481 | 119 | 9 | GO:0005769 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.97e-03 | 93 | 119 | 4 | GO:0030864 | |
| GeneOntologyCellularComponent | platelet alpha granule | 1.97e-03 | 93 | 119 | 4 | GO:0031091 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.04e-03 | 591 | 119 | 10 | GO:0005911 | |
| GeneOntologyCellularComponent | cuticular plate | 2.41e-03 | 13 | 119 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | glial cell projection | 2.43e-03 | 47 | 119 | 3 | GO:0097386 | |
| GeneOntologyCellularComponent | endosome | FKBP15 STAM2 ANK2 INSR KIF16B VPS16 APP NCDN ATP6V1H ZFYVE9 FCGR2A SLC2A13 RASSF9 NBR1 SLC9A6 | 2.59e-03 | 1167 | 119 | 15 | GO:0005768 |
| GeneOntologyCellularComponent | kinesin complex | 2.74e-03 | 49 | 119 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | neurofilament | 2.80e-03 | 14 | 119 | 2 | GO:0005883 | |
| GeneOntologyCellularComponent | growth cone | 2.81e-03 | 245 | 119 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.29e-03 | 253 | 119 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | ciliary rootlet | 3.66e-03 | 16 | 119 | 2 | GO:0035253 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 3.87e-03 | 443 | 119 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | ciliary base | 4.00e-03 | 56 | 119 | 3 | GO:0097546 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 4.13e-03 | 17 | 119 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 4.17e-03 | 185 | 119 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | ciliary basal body | 5.20e-03 | 195 | 119 | 5 | GO:0036064 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TCHP DISC1 KIF16B TOGARAM1 VPS16 BICD1 DST TIAM1 KIF5B DMD MTUS2 PRPH | 5.20e-03 | 899 | 119 | 12 | GO:0099513 |
| GeneOntologyCellularComponent | postsynapse | TANC2 ANK1 ANK2 MARK1 DISC1 CAPN2 APP NCDN DST TIAM1 FCGR2A KIF5B DMD | 5.29e-03 | 1018 | 119 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 5.71e-03 | 20 | 119 | 2 | GO:0016010 | |
| MousePheno | impaired skeletal muscle contractility | 1.27e-05 | 44 | 97 | 5 | MP:0002841 | |
| Domain | Myosin_N | 2.41e-10 | 15 | 116 | 6 | PF02736 | |
| Domain | Myosin_N | 2.41e-10 | 15 | 116 | 6 | IPR004009 | |
| Domain | Myosin_tail_1 | 8.80e-10 | 18 | 116 | 6 | PF01576 | |
| Domain | Myosin_tail | 8.80e-10 | 18 | 116 | 6 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.28e-09 | 19 | 116 | 6 | IPR027401 | |
| Domain | - | 1.28e-09 | 19 | 116 | 6 | 4.10.270.10 | |
| Domain | IQ | 1.14e-07 | 93 | 116 | 8 | PS50096 | |
| Domain | Myosin_head_motor_dom | 1.18e-07 | 38 | 116 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.18e-07 | 38 | 116 | 6 | PS51456 | |
| Domain | Myosin_head | 1.18e-07 | 38 | 116 | 6 | PF00063 | |
| Domain | MYSc | 1.18e-07 | 38 | 116 | 6 | SM00242 | |
| Domain | IQ | 2.84e-07 | 71 | 116 | 7 | PF00612 | |
| Domain | IQ | 7.07e-07 | 81 | 116 | 7 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.45e-06 | 90 | 116 | 7 | IPR000048 | |
| Domain | P-loop_NTPase | TANC2 MYH1 MYH2 MYH4 MYH6 MYH13 KIF16B BMS1 NAIP RFC1 AK7 MSH6 PALS1 TRANK1 MDN1 MYH15 KIF5B HYDIN | 4.76e-06 | 848 | 116 | 18 | IPR027417 |
| Domain | EF-hand-dom_pair | 1.22e-05 | 287 | 116 | 10 | IPR011992 | |
| Domain | Mo25 | 3.82e-05 | 2 | 116 | 2 | IPR013878 | |
| Domain | Mo25 | 3.82e-05 | 2 | 116 | 2 | PF08569 | |
| Domain | EF_Hand_1_Ca_BS | 1.11e-04 | 175 | 116 | 7 | IPR018247 | |
| Domain | ZF_ZZ_2 | 1.78e-04 | 18 | 116 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.78e-04 | 18 | 116 | 3 | PS01357 | |
| Domain | ZZ | 1.78e-04 | 18 | 116 | 3 | PF00569 | |
| Domain | Znf_ZZ | 2.10e-04 | 19 | 116 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 2.10e-04 | 19 | 116 | 3 | SM00291 | |
| Domain | - | 2.26e-04 | 261 | 116 | 8 | 1.10.238.10 | |
| Domain | Parvalbumin | 3.78e-04 | 5 | 116 | 2 | IPR008080 | |
| Domain | Na_trans_cytopl | 5.64e-04 | 6 | 116 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 5.64e-04 | 6 | 116 | 2 | IPR024583 | |
| Domain | EF-hand_dom_typ1 | 5.64e-04 | 6 | 116 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 5.64e-04 | 6 | 116 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 5.64e-04 | 6 | 116 | 2 | PF09068 | |
| Domain | EF-hand_3 | 5.64e-04 | 6 | 116 | 2 | PF09069 | |
| Domain | DEATH | 6.12e-04 | 27 | 116 | 3 | SM00005 | |
| Domain | - | 9.13e-04 | 248 | 116 | 7 | 1.25.40.20 | |
| Domain | ANK_REPEAT | 1.03e-03 | 253 | 116 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.05e-03 | 254 | 116 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.05e-03 | 254 | 116 | 7 | PS50297 | |
| Domain | Death | 1.11e-03 | 33 | 116 | 3 | PF00531 | |
| Domain | Ankyrin_rpt | 1.26e-03 | 262 | 116 | 7 | IPR002110 | |
| Domain | ZU5 | 1.34e-03 | 9 | 116 | 2 | SM00218 | |
| Domain | Na_channel_asu | 1.67e-03 | 10 | 116 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.67e-03 | 10 | 116 | 2 | IPR010526 | |
| Domain | HAT | 1.67e-03 | 10 | 116 | 2 | SM00386 | |
| Domain | Na_trans_assoc | 1.67e-03 | 10 | 116 | 2 | PF06512 | |
| Domain | ZU5 | 1.67e-03 | 10 | 116 | 2 | PS51145 | |
| Domain | HAT | 1.67e-03 | 10 | 116 | 2 | IPR003107 | |
| Domain | Death_domain | 1.68e-03 | 38 | 116 | 3 | IPR000488 | |
| Domain | DEATH_DOMAIN | 1.68e-03 | 38 | 116 | 3 | PS50017 | |
| Domain | EF_HAND_1 | 1.73e-03 | 204 | 116 | 6 | PS00018 | |
| Domain | EF-hand_7 | 1.94e-03 | 85 | 116 | 4 | PF13499 | |
| Domain | SH3 | 2.31e-03 | 216 | 116 | 6 | PS50002 | |
| Domain | ZU5 | 2.42e-03 | 12 | 116 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.42e-03 | 12 | 116 | 2 | IPR000906 | |
| Domain | SH3_domain | 2.53e-03 | 220 | 116 | 6 | IPR001452 | |
| Domain | EFh | 3.07e-03 | 158 | 116 | 5 | SM00054 | |
| Domain | EF_HAND_2 | 3.22e-03 | 231 | 116 | 6 | PS50222 | |
| Domain | EF_hand_dom | 3.28e-03 | 232 | 116 | 6 | IPR002048 | |
| Domain | SH3_1 | 3.60e-03 | 164 | 116 | 5 | PF00018 | |
| Domain | ANK | 4.82e-03 | 251 | 116 | 6 | SM00248 | |
| Domain | Interferon | 4.89e-03 | 17 | 116 | 2 | PF00143 | |
| Domain | INTERFERON_A_B_D | 4.89e-03 | 17 | 116 | 2 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 4.89e-03 | 17 | 116 | 2 | IPR000471 | |
| Domain | IFabd | 4.89e-03 | 17 | 116 | 2 | SM00076 | |
| Domain | ARM-type_fold | 5.26e-03 | 339 | 116 | 7 | IPR016024 | |
| Domain | Furin_repeat | 5.48e-03 | 18 | 116 | 2 | IPR006212 | |
| Domain | FU | 5.48e-03 | 18 | 116 | 2 | SM00261 | |
| Domain | BRCT | 6.10e-03 | 19 | 116 | 2 | PF00533 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 3.43e-07 | 70 | 92 | 7 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 2.43e-05 | 132 | 92 | 7 | M11355 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.67e-05 | 31 | 92 | 4 | M877 | |
| Pubmed | SART3 STAM2 FRAS1 ANK2 TCHP DTNA ECD NUCB2 KIF16B BMS1 MRPS35 UFL1 APP PGRMC1 PREPL NCDN LETM1 MDN1 TIAM1 ARHGEF10 RRP9 NUP133 TMX3 ESPL1 NBR1 GOLGA4 GOLGB1 | 7.99e-13 | 1487 | 119 | 27 | 33957083 | |
| Pubmed | 1.30e-10 | 4 | 119 | 4 | 10388558 | ||
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 1.78e-10 | 111 | 119 | 9 | 22558309 | |
| Pubmed | STAM2 MARK1 DTNA INSR UFL1 APP PALS1 DST ZFYVE9 TFB1M ARHGEF10 CIBAR1 DMD GOLGB1 | 2.18e-10 | 421 | 119 | 14 | 36976175 | |
| Pubmed | SART3 PDS5B MYH1 MYH2 MYH4 MYH6 ANK2 MYH13 DTNA ECD NUCB2 MRPS35 FNBP1L LETM1 LIG4 DST MDN1 CC2D2A MYH15 KIF5B DMD GOLGB1 PRPH | 6.45e-10 | 1442 | 119 | 23 | 35575683 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.94e-09 | 6 | 119 | 4 | 10077619 | |
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 35210422 | ||
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 16819597 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 9.02e-09 | 8 | 119 | 4 | 14667415 | |
| Pubmed | 1.08e-08 | 22 | 119 | 5 | 24301466 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 3.91e-08 | 3 | 119 | 3 | 26059207 | |
| Pubmed | Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle. | 3.91e-08 | 3 | 119 | 3 | 15013776 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SART3 FKBP15 DTNA POLDIP3 ECD CAPN2 BMS1 MRPS35 PGRMC1 PREPL MSH6 ATP6V1H CIBAR1 NUP133 DMD TMX3 ESPL1 | 3.92e-08 | 974 | 119 | 17 | 28675297 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 PDS5B POLDIP3 BMS1 MRPS35 UFL1 RFC1 PGRMC1 LETM1 GLMN MSH6 CRNKL1 ATP6V1H MDN1 RRP9 NUP133 CC2D2A KIF5B NBR1 GOLGA4 | 7.99e-08 | 1425 | 119 | 20 | 30948266 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CAB39 MYH1 FKBP15 MYH2 MYH6 MYH13 MARK1 DTNA INSR PGRMC1 RTF1 DST NUP133 MYH15 ESPL1 CFAP97 | 9.23e-08 | 910 | 119 | 16 | 36736316 |
| Pubmed | 1.27e-07 | 14 | 119 | 4 | 24938781 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.56e-07 | 4 | 119 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.56e-07 | 4 | 119 | 3 | 18417546 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 11023856 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 2.30e-07 | 16 | 119 | 4 | 19922871 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 MYH4 ANK1 DISC1 BMS1 PARP14 MSH6 DST MDN1 SYDE2 SCN3A PWWP3B CFAP57 BANK1 | 2.44e-07 | 736 | 119 | 14 | 29676528 |
| Pubmed | SART3 KIF16B BMS1 UFL1 PREPL TRANK1 DST KDM7A TMX3 ESPL1 NBR1 CFAP97 | 2.94e-07 | 529 | 119 | 12 | 14621295 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 3.89e-07 | 5 | 119 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 3.89e-07 | 5 | 119 | 3 | 12919077 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 3.89e-07 | 5 | 119 | 3 | 30737693 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 6196357 | ||
| Pubmed | SART3 MYH2 POLDIP3 ECD BMS1 MRPS35 UFL1 RFC1 PGRMC1 LETM1 GLMN MSH6 ATP6V1H DST MDN1 NFKB1 NUP133 TMX3 LRRFIP1 | 4.49e-07 | 1440 | 119 | 19 | 30833792 | |
| Pubmed | PDS5B ECD CAPN2 VPS16 RFC1 NCDN LETM1 GLMN MSH6 ATP6V1H NUP133 TMX3 | 5.37e-07 | 560 | 119 | 12 | 35241646 | |
| Pubmed | HMGN5 STAM2 DTNA BMS1 APP LETM1 GLMN MSH6 ZFYVE9 TIAM1 NFKB1 NUP133 TMF1 DMD NBR1 GOLGA4 | 6.16e-07 | 1049 | 119 | 16 | 27880917 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 1728586 | ||
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 7.75e-07 | 6 | 119 | 3 | 17559643 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 7.75e-07 | 6 | 119 | 3 | 10588881 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | POLDIP3 KIF16B BMS1 MRPS35 UFL1 PREPL LETM1 GLMN DST MDN1 UPF2 NDC80 RRP9 NUP133 FGA R3HDM1 ESPL1 NBR1 GOLGB1 | 7.96e-07 | 1496 | 119 | 19 | 32877691 |
| Pubmed | 9.43e-07 | 151 | 119 | 7 | 17043677 | ||
| Pubmed | 1.08e-06 | 97 | 119 | 6 | 22360420 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.35e-06 | 7 | 119 | 3 | 29758057 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 33667029 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 26993635 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 3864153 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 36200826 | ||
| Pubmed | SART3 PDS5B POLDIP3 BMS1 RFC1 MSH6 CRNKL1 DST MDN1 RRP9 NUP133 KIF5B | 2.65e-06 | 653 | 119 | 12 | 22586326 | |
| Pubmed | 3.23e-06 | 9 | 119 | 3 | 31960486 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.76e-06 | 120 | 119 | 6 | 31413325 | |
| Pubmed | 3.82e-06 | 31 | 119 | 4 | 21985497 | ||
| Pubmed | 4.61e-06 | 10 | 119 | 3 | 22750946 | ||
| Pubmed | TANC2 FKBP15 ANK2 PREPL NCDN LETM1 PALS1 DST MDN1 KIF5B ARHGEF26 GOLGA4 GOLGB1 LRRFIP1 | 5.67e-06 | 963 | 119 | 14 | 28671696 | |
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 18310078 | ||
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 6.32e-06 | 11 | 119 | 3 | 16024798 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 6.32e-06 | 11 | 119 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 6.32e-06 | 11 | 119 | 3 | 29168801 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 ECD CAPN2 MRPS35 UFL1 FNBP1L RFC1 NCDN LETM1 RTF1 MSH6 CRNKL1 KIF5B NBR1 GOLGA4 GOLGB1 LRRFIP1 | 6.72e-06 | 1415 | 119 | 17 | 28515276 |
| Pubmed | TANC2 SART3 CAB39 MYH6 AMPH ANK2 MARK1 NCDN LETM1 ATP6V1H DST UPF2 FGA KIF5B DMD MTUS2 LRRFIP1 | 7.78e-06 | 1431 | 119 | 17 | 37142655 | |
| Pubmed | 9.77e-06 | 39 | 119 | 4 | 38690566 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 PDS5B POLDIP3 ECD INSR MRPS35 NCDN ORC2 CRNKL1 NDC80 RRP9 NUP133 FGA ESPL1 CFAP97 | 9.90e-06 | 1155 | 119 | 15 | 20360068 |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.09e-05 | 13 | 119 | 3 | 8404542 | |
| Pubmed | 1.09e-05 | 13 | 119 | 3 | 24876128 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B POLDIP3 INSR UFL1 APP PGRMC1 NCDN CRNKL1 DST MDN1 RRP9 NUP133 KIF5B GOLGB1 | 1.13e-05 | 1024 | 119 | 14 | 24711643 |
| Pubmed | Structure and chromosomal localization of the mouse oncomodulin gene. | 1.16e-05 | 2 | 119 | 2 | 8597631 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23798567 | ||
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 1.16e-05 | 2 | 119 | 2 | 9585413 | |
| Pubmed | TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation. | 1.16e-05 | 2 | 119 | 2 | 31468715 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 14516679 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 2474657 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25710816 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16575183 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 1.16e-05 | 2 | 119 | 2 | 24990319 | |
| Pubmed | Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells. | 1.16e-05 | 2 | 119 | 2 | 37228645 | |
| Pubmed | Hypoxic preconditioning decreases nuclear factor κB activity via Disrupted in Schizophrenia-1. | 1.16e-05 | 2 | 119 | 2 | 26615762 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 1.16e-05 | 2 | 119 | 2 | 9382868 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11150240 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 1.16e-05 | 2 | 119 | 2 | 22337492 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24123596 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27690330 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26991731 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24821909 | ||
| Pubmed | Myosin gene mutation correlates with anatomical changes in the human lineage. | 1.16e-05 | 2 | 119 | 2 | 15042088 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16490783 | ||
| Pubmed | Truncations of amphiphysin I by calpain inhibit vesicle endocytosis during neural hyperexcitation. | 1.16e-05 | 2 | 119 | 2 | 17541403 | |
| Pubmed | Disulfide-linked dimer of oncomodulin: comparison to calmodulin. | 1.16e-05 | 2 | 119 | 2 | 3179268 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 1.16e-05 | 2 | 119 | 2 | 23965409 | |
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 1.16e-05 | 2 | 119 | 2 | 11551968 | |
| Pubmed | Novel genes and mutations in patients affected by recurrent pregnancy loss. | 1.16e-05 | 2 | 119 | 2 | 29016666 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 31413358 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25561733 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23043099 | ||
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 1.16e-05 | 2 | 119 | 2 | 7545970 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 37642186 | ||
| Pubmed | Distinct fetal Ank-1 and Ank-2 related proteins and mRNAs in normal and nb/nb mice. | 1.16e-05 | 2 | 119 | 2 | 8471772 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8611623 | ||
| Pubmed | Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. | 1.16e-05 | 2 | 119 | 2 | 17855343 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20547855 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21102503 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 37652204 | ||
| Pubmed | Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1. | 1.16e-05 | 2 | 119 | 2 | 29674524 | |
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 1.16e-05 | 2 | 119 | 2 | 11744674 | |
| Pubmed | 1.38e-05 | 14 | 119 | 3 | 27184118 | ||
| Pubmed | 1.38e-05 | 14 | 119 | 3 | 33742095 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 PDS5B POLDIP3 CAPN2 BMS1 VPS16 RFC1 MSH6 CRNKL1 DST MDN1 TFB1M UPF2 NUP133 KIF5B GOLGA4 | 1.56e-05 | 1353 | 119 | 16 | 29467282 |
| Interaction | GJA1 interactions | STAM2 MYH6 CNST MARK1 DTNA INSR KIF16B UFL1 DST ZFYVE9 TIAM1 ARHGEF10 FGA TMF1 NBR1 GOLGA4 GOLGB1 | 5.84e-08 | 583 | 119 | 17 | int:GJA1 |
| Interaction | EPHA2 interactions | STAM2 MARK1 DTNA INSR MRPS35 UFL1 APP NPHP4 PALS1 DST ZFYVE9 TIAM1 TFB1M ARHGEF10 CIBAR1 DMD GOLGB1 | 1.11e-06 | 719 | 119 | 17 | int:EPHA2 |
| Interaction | CDK3 interactions | 5.12e-06 | 114 | 119 | 7 | int:CDK3 | |
| Interaction | LIMD1 interactions | 8.92e-06 | 124 | 119 | 7 | int:LIMD1 | |
| Interaction | LATS1 interactions | MYH1 MYH2 MYH4 MYH6 MYH13 TCHP APP NPHP4 PALS1 MDN1 CEP70 R3HDM1 | 1.16e-05 | 440 | 119 | 12 | int:LATS1 |
| Interaction | RNF123 interactions | MYH1 MYH4 ANK1 DISC1 BMS1 APP PARP14 MSH6 DST MDN1 SYDE2 NFKB1 SCN3A PWWP3B CFAP57 BANK1 | 2.77e-05 | 824 | 119 | 16 | int:RNF123 |
| Interaction | DTNB interactions | 3.00e-05 | 101 | 119 | 6 | int:DTNB | |
| Interaction | BIRC3 interactions | SART3 PDS5B POLDIP3 BMS1 MRPS35 UFL1 RFC1 PGRMC1 LETM1 GLMN MSH6 CRNKL1 ATP6V1H MDN1 RRP9 NFKB1 NUP133 CC2D2A KIF5B NBR1 GOLGA4 | 3.29e-05 | 1334 | 119 | 21 | int:BIRC3 |
| Interaction | KRT6A interactions | 4.64e-05 | 160 | 119 | 7 | int:KRT6A | |
| Interaction | RSPH6A interactions | 4.67e-05 | 34 | 119 | 4 | int:RSPH6A | |
| Interaction | PLEKHG1 interactions | 4.76e-05 | 67 | 119 | 5 | int:PLEKHG1 | |
| Interaction | IFITM1 interactions | FKBP15 STAM2 KIF16B VPS16 APP PGRMC1 ZFYVE9 NBR1 GOLGA4 GOLGB1 | 4.92e-05 | 355 | 119 | 10 | int:IFITM1 |
| Interaction | IFITM3 interactions | FKBP15 STAM2 POLDIP3 KIF16B VPS16 APP PGRMC1 LETM1 ATP6V1H ZFYVE9 GOLGA4 GOLGB1 | 5.23e-05 | 513 | 119 | 12 | int:IFITM3 |
| Interaction | KRT8 interactions | 6.15e-05 | 441 | 119 | 11 | int:KRT8 | |
| Interaction | C9orf78 interactions | PDS5B ECD CAPN2 VPS16 RFC1 APP NCDN LETM1 GLMN MSH6 ATP6V1H NUP133 TMX3 | 7.69e-05 | 620 | 119 | 13 | int:C9orf78 |
| Interaction | GJD3 interactions | STAM2 INSR UFL1 PGRMC1 DST ZFYVE9 TMF1 TMX3 NBR1 GOLGA4 GOLGB1 | 7.97e-05 | 454 | 119 | 11 | int:GJD3 |
| Interaction | LYPD4 interactions | 9.04e-05 | 123 | 119 | 6 | int:LYPD4 | |
| Interaction | YWHAQ interactions | TANC2 MYH2 STAM2 MYH13 MARK1 DISC1 UFL1 RFC1 APP DST TIAM1 SYDE2 NFKB1 FGA KIF5B R3HDM1 BANK1 GOLGB1 | 9.73e-05 | 1118 | 119 | 18 | int:YWHAQ |
| Interaction | AMOT interactions | 9.92e-05 | 312 | 119 | 9 | int:AMOT | |
| Interaction | BCAP31 interactions | MYH1 MYH2 MYH4 MYH6 FRAS1 MYH13 UFL1 APP PGRMC1 MYH15 TMX3 CFAP97 | 1.09e-04 | 554 | 119 | 12 | int:BCAP31 |
| Interaction | BIN1 interactions | 1.18e-04 | 129 | 119 | 6 | int:BIN1 | |
| Interaction | FLOT1 interactions | 1.19e-04 | 475 | 119 | 11 | int:FLOT1 | |
| GeneFamily | Myosin heavy chains | 1.32e-13 | 15 | 78 | 7 | 1098 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.02e-05 | 18 | 78 | 3 | 91 | |
| GeneFamily | Ankyrin repeat domain containing | 8.31e-05 | 242 | 78 | 7 | 403 | |
| GeneFamily | EF-hand domain containing | 3.66e-04 | 219 | 78 | 6 | 863 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.49e-04 | 9 | 78 | 2 | 1203 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.91e-03 | 66 | 78 | 3 | 722 | |
| GeneFamily | PWWP domain containing | 4.01e-03 | 22 | 78 | 2 | 1147 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B AMPH TOGARAM1 FNBP1L APP BICD1 ORC2 MSH6 ATP6V1H DST MDN1 ZFYVE9 TIAM1 UPF2 NDC80 ARHGEF10 NFKB1 NUP133 DMD R3HDM1 GOLGA4 LRRFIP1 | 4.02e-11 | 856 | 119 | 22 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.13e-07 | 84 | 119 | 7 | M13008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 2.52e-06 | 85 | 119 | 6 | M10575 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 2.12e-05 | 417 | 119 | 10 | M39224 | |
| Coexpression | PGF_UP.V1_UP | 2.66e-05 | 190 | 119 | 7 | M2674 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.69e-05 | 200 | 119 | 7 | M291 | |
| Coexpression | HALLMARK_MYOGENESIS | 3.69e-05 | 200 | 119 | 7 | M5909 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | PDS5B NUCB2 KIF16B UFL1 RFC1 LIG4 NDC80 CEP70 TMF1 KIF5B GOLGA4 GOLGB1 | 4.53e-05 | 656 | 119 | 12 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 5.42e-05 | 466 | 119 | 10 | M13522 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#2_top-relative-expression-ranked_500 | 2.90e-06 | 114 | 115 | 7 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | HMGN5 ANKRD42 ANK2 DTNA UFL1 FNBP1L RFC1 BICD1 ORC2 MSH6 LIG4 MDN1 OCM UPF2 NDC80 CIBAR1 CEP70 PWWP3B DMD R3HDM1 CFAP97 | 3.52e-06 | 1257 | 115 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#5_top-relative-expression-ranked_200 | 1.09e-05 | 54 | 115 | 5 | gudmap_developingKidney_e15.5_Podocyte cells_200_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | HMGN5 ANKRD42 ANK2 DTNA UFL1 FNBP1L RFC1 BICD1 ORC2 MSH6 LIG4 MDN1 OCM UPF2 NDC80 CIBAR1 CEP70 PWWP3B DMD R3HDM1 CFAP97 | 3.36e-05 | 1459 | 115 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | MYH1 MYH2 ANK1 DTNA HTATIP2 INSR NAIP LAMA4 PARP14 DST DMD BANK1 MTUS2 LRRFIP1 | 4.34e-05 | 734 | 115 | 14 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | HMGN5 CAB39 UFL1 MSH6 DST ZFYVE9 UPF2 TMF1 CAB39L KIF5B TMX3 | 4.90e-05 | 469 | 115 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#1_top-relative-expression-ranked_200 | 7.80e-05 | 42 | 115 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k1_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 8.45e-05 | 259 | 115 | 8 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | FRAS1 MARK1 KIF16B DNAAF9 PARP14 DST TIAM1 CCDC149 SYDE2 ATP2C2 CEP70 DMD RASSF9 LRRFIP1 | 1.09e-04 | 800 | 115 | 14 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_500 | 1.52e-04 | 93 | 115 | 5 | gudmap_developingKidney_e15.5_Endothelial cells_500_k5 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.44e-09 | 199 | 119 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.61e-08 | 195 | 119 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.13e-08 | 77 | 119 | 6 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.01e-07 | 177 | 119 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-07 | 184 | 119 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-07 | 184 | 119 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-07 | 184 | 119 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 8.06e-07 | 190 | 119 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.35e-07 | 191 | 119 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.95e-07 | 193 | 119 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.27e-07 | 194 | 119 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 9.27e-07 | 194 | 119 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 9.92e-07 | 196 | 119 | 7 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-06 | 198 | 119 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-06 | 198 | 119 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.06e-06 | 198 | 119 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-06 | 198 | 119 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.10e-06 | 199 | 119 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 199 | 119 | 7 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.10e-06 | 199 | 119 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.14e-06 | 200 | 119 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.92e-06 | 176 | 119 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.29e-06 | 181 | 119 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.59e-06 | 182 | 119 | 6 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-06 | 182 | 119 | 6 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 9.89e-06 | 183 | 119 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 185 | 119 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.05e-05 | 185 | 119 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-05 | 186 | 119 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.08e-05 | 186 | 119 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 187 | 119 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 189 | 119 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 189 | 119 | 6 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 190 | 119 | 6 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.26e-05 | 191 | 119 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-05 | 191 | 119 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.30e-05 | 192 | 119 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.34e-05 | 193 | 119 | 6 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.34e-05 | 193 | 119 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.38e-05 | 194 | 119 | 6 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.38e-05 | 194 | 119 | 6 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-05 | 195 | 119 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 198 | 119 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-05 | 198 | 119 | 6 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-05 | 199 | 119 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.59e-05 | 199 | 119 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.59e-05 | 199 | 119 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-05 | 199 | 119 | 6 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.59e-05 | 199 | 119 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.31e-05 | 62 | 119 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.31e-05 | 62 | 119 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 145 | 119 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 7.25e-05 | 161 | 119 | 5 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.46e-05 | 162 | 119 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 8.86e-05 | 168 | 119 | 5 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 169 | 119 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.37e-05 | 170 | 119 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.63e-05 | 171 | 119 | 5 | 23b3120706bb9c20b9214fe3760c6d7a84f1e749 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 175 | 119 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 178 | 119 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 178 | 119 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 182 | 119 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.29e-04 | 182 | 119 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 182 | 119 | 5 | eb4be1c02b8b033d025e57b8b4cdbfaec4698054 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.29e-04 | 182 | 119 | 5 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 183 | 119 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.32e-04 | 183 | 119 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-04 | 184 | 119 | 5 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.36e-04 | 184 | 119 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 184 | 119 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.39e-04 | 185 | 119 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.39e-04 | 185 | 119 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.43e-04 | 186 | 119 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 186 | 119 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.43e-04 | 186 | 119 | 5 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 1.43e-04 | 186 | 119 | 5 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.46e-04 | 187 | 119 | 5 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.46e-04 | 187 | 119 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.46e-04 | 187 | 119 | 5 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 187 | 119 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 187 | 119 | 5 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.46e-04 | 187 | 119 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.50e-04 | 188 | 119 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 188 | 119 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 188 | 119 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.50e-04 | 188 | 119 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 188 | 119 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.50e-04 | 188 | 119 | 5 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.50e-04 | 188 | 119 | 5 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 190 | 119 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 190 | 119 | 5 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.58e-04 | 190 | 119 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.58e-04 | 190 | 119 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| Drug | oxovanadium | 1.38e-08 | 120 | 119 | 9 | CID000024411 | |
| Drug | B0683 | 1.86e-07 | 117 | 119 | 8 | CID006398969 | |
| Drug | AC1N9ZZC | 1.18e-06 | 149 | 119 | 8 | CID004369374 | |
| Drug | fast white | 2.61e-06 | 42 | 119 | 5 | CID000024008 | |
| Drug | N-ethylmaleimide | MYH1 MYH2 MYH4 MYH6 MYH13 DTNA DISC1 INSR KIF16B VPS16 ATP2C2 KIF5B GOLGB1 | 2.82e-06 | 511 | 119 | 13 | CID000004362 |
| Drug | wartmannin | MYH1 MYH2 MYH4 MYH6 MYH13 INSR LIG4 ZFYVE9 TIAM1 UPF2 NDC80 FCGR2A NFKB1 FGA SLC2A13 GOLGB1 | 5.08e-06 | 811 | 119 | 16 | CID000005691 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 5.48e-06 | 183 | 119 | 8 | 7498_DN | |
| Drug | formycin triphosphate | 6.95e-06 | 51 | 119 | 5 | CID000122274 | |
| Drug | creatine | 8.10e-06 | 193 | 119 | 8 | CID000000586 | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 8.41e-06 | 194 | 119 | 8 | 3725_DN | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A | 9.07e-06 | 196 | 119 | 8 | 4075_UP | |
| Drug | clenbuterol | 9.90e-06 | 142 | 119 | 7 | CID000002783 | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.01e-05 | 199 | 119 | 8 | 4219_UP | |
| Drug | candesartan cilexetil | 1.14e-05 | 145 | 119 | 7 | CID000002540 | |
| Drug | purealin | 1.32e-05 | 58 | 119 | 5 | CID006419303 | |
| Drug | carvedilol | 2.24e-05 | 161 | 119 | 7 | CID000002585 | |
| Drug | Air Pollutants | FRAS1 DNAAF9 FNBP1L RFC1 PARP14 AK7 LIG4 TRANK1 NDC80 CEP70 FGA NBR1 REXO1L1P GALNT4 LRRFIP1 LARGE1 | 2.33e-05 | 917 | 119 | 16 | ctd:D000393 |
| Drug | NSC381866 | 3.06e-05 | 169 | 119 | 7 | CID000002287 | |
| Drug | NSC107658 | 3.38e-05 | 306 | 119 | 9 | CID000002919 | |
| Drug | Ikvav | 4.56e-05 | 38 | 119 | 4 | CID000131343 | |
| Drug | 2bq7 | 4.64e-05 | 123 | 119 | 6 | CID006540267 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 6643_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 4813_DN | |
| Drug | Methacholine chloride [62-51-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 3452_DN | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; HL60; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 2734_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 6629_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HG-U133A | 8.60e-05 | 199 | 119 | 7 | 426_UP | |
| Drug | SM-2 | 9.41e-05 | 87 | 119 | 5 | CID000486033 | |
| Drug | 4-chloroaniline | 9.44e-05 | 202 | 119 | 7 | CID000007812 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 6.04e-13 | 10 | 114 | 6 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 6.04e-13 | 10 | 114 | 6 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 6.04e-13 | 10 | 114 | 6 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 6.04e-13 | 10 | 114 | 6 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 6.04e-13 | 10 | 114 | 6 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 6.04e-13 | 10 | 114 | 6 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 6.04e-13 | 10 | 114 | 6 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 6.04e-13 | 10 | 114 | 6 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.64e-12 | 12 | 114 | 6 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.64e-12 | 12 | 114 | 6 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.89e-12 | 13 | 114 | 6 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.42e-11 | 15 | 114 | 6 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.68e-08 | 80 | 114 | 7 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 3.13e-08 | 48 | 114 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.40e-07 | 71 | 114 | 6 | DOID:0050700 (implicated_via_orthology) | |
| Disease | sick sinus syndrome (is_implicated_in) | 1.47e-04 | 5 | 114 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | Cardiomyopathies | 1.54e-04 | 130 | 114 | 5 | C0878544 | |
| Disease | internet addiction disorder | 2.82e-04 | 33 | 114 | 3 | EFO_0803368 | |
| Disease | Joubert syndrome (implicated_via_orthology) | 3.07e-04 | 7 | 114 | 2 | DOID:0050777 (implicated_via_orthology) | |
| Disease | lymphoid leukemia (is_implicated_in) | 3.07e-04 | 7 | 114 | 2 | DOID:1037 (is_implicated_in) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.65e-04 | 36 | 114 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Meckel syndrome (implicated_via_orthology) | 4.08e-04 | 8 | 114 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | ciliopathy (implicated_via_orthology) | 5.00e-04 | 40 | 114 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | cognitive disorder (is_implicated_in) | 5.23e-04 | 9 | 114 | 2 | DOID:1561 (is_implicated_in) | |
| Disease | malaria (implicated_via_orthology) | 5.23e-04 | 9 | 114 | 2 | DOID:12365 (implicated_via_orthology) | |
| Disease | Thrombophilia | 5.23e-04 | 9 | 114 | 2 | C0398623 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.52e-04 | 10 | 114 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.52e-04 | 10 | 114 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 6.63e-04 | 44 | 114 | 3 | C0340427 | |
| Disease | diffuse scleroderma (is_implicated_in) | 7.95e-04 | 11 | 114 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | factor VIII deficiency (is_implicated_in) | 7.95e-04 | 11 | 114 | 2 | DOID:12134 (is_implicated_in) | |
| Disease | visual epilepsy (is_implicated_in) | 7.95e-04 | 11 | 114 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 9.52e-04 | 12 | 114 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Drug habituation | 1.05e-03 | 115 | 114 | 4 | C0013170 | |
| Disease | Drug abuse | 1.05e-03 | 115 | 114 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.05e-03 | 115 | 114 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.05e-03 | 115 | 114 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.05e-03 | 115 | 114 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.05e-03 | 115 | 114 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.05e-03 | 115 | 114 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.05e-03 | 115 | 114 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.05e-03 | 115 | 114 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.08e-03 | 116 | 114 | 4 | C0740858 | |
| Disease | MMR-related febrile seizures | 1.50e-03 | 15 | 114 | 2 | EFO_0006519 | |
| Disease | Intellectual Disability | 1.79e-03 | 447 | 114 | 7 | C3714756 | |
| Disease | Cerebrovascular accident | 1.80e-03 | 62 | 114 | 3 | C0038454 | |
| Disease | schizophrenia, inflammatory bowel disease | 2.17e-03 | 18 | 114 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | hydrocephalus (implicated_via_orthology) | 2.42e-03 | 19 | 114 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | emphysema imaging measurement | 2.52e-03 | 146 | 114 | 4 | EFO_0007626 | |
| Disease | Malignant neoplasm of breast | MYH1 ANK1 ANK2 KIF16B MSH6 RRP9 NUP133 DMD MMP10 GOLGB1 LRRFIP1 | 2.99e-03 | 1074 | 114 | 11 | C0006142 |
| Disease | anxiety disorder (implicated_via_orthology) | 3.25e-03 | 22 | 114 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.27e-03 | 157 | 114 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.74e-03 | 163 | 114 | 4 | DOID:1826 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IDINNEQENDYEEDI | 406 | Q8NDB2 | |
| DNKESLENISENDDY | 816 | Q13075 | |
| ERTDDEQFADEKNYL | 311 | Q9H9S4 | |
| KYDTNNNEEEEGEQF | 41 | O15013 | |
| NVSQEIYEDVEDLKN | 286 | Q9P2B7 | |
| QYDELEAEYDSLKQE | 51 | Q96G01 | |
| EVDELLQKEQNYSDD | 561 | P05067 | |
| EQEQASKEYDEDSLI | 876 | P16157 | |
| KRQLEETNNDYETAD | 271 | P12318 | |
| NDRTEDEQFNDEKTY | 311 | Q9Y376 | |
| QNYKEKALDIDSDEE | 381 | Q96DR7 | |
| ADLEEENRNLQAEYD | 3511 | P11532 | |
| IENLLKEEEDYKEEN | 641 | Q14692 | |
| QEDAVENDDYDKAET | 361 | Q9NRI5 | |
| ENDDYDKAETLQQRL | 366 | Q9NRI5 | |
| KEEKEQNYDLTEVSE | 441 | O95905 | |
| EANQNYLADEEEEAE | 26 | Q9UN42 | |
| QYQALEKDEEEALID | 21 | O75185 | |
| ADETKDEQFEEYVQN | 31 | P49418 | |
| LLEELQKYDIDDENE | 321 | Q8N9B4 | |
| QKYDIDDENEIDEND | 326 | Q8N9B4 | |
| DDENEIDENDVKYFI | 331 | Q8N9B4 | |
| EQEALEKDQERLEYE | 1056 | Q96L93 | |
| LSEENANLQEYVEKE | 1301 | Q5JR59 | |
| QENYIIDKRLQDEDA | 306 | Q15032 | |
| NLDLQYEENQTLEDL | 246 | O75901 | |
| DQDSEEEKELYLNLA | 46 | Q9NTI5 | |
| EELAVNYDQKSQEVE | 496 | P33176 | |
| DNDKYQQFRLSEETE | 2146 | Q01484 | |
| EEDSNKDLAQQYLEK | 26 | P09238 | |
| HLESQELDEQIYQED | 436 | P41212 | |
| EYIDEEEDININDLK | 1056 | Q8WUM0 | |
| DQSLYTADSENEEDK | 596 | Q6ZMT4 | |
| QKQLSELDEDDLCYE | 431 | O95461 | |
| EDKINEQIDERDYDE | 4846 | Q9NU22 | |
| DDSLIYDNEGDQVKN | 3861 | Q86XX4 | |
| NQEVVDFEKLDDYAS | 66 | Q9BUP3 | |
| KTLYEEAEEANDLSQ | 426 | Q9UBB6 | |
| LQEEFDASLEEKDQY | 206 | Q13439 | |
| YDQEREEKIKQEQED | 1971 | Q13439 | |
| DLDDQKIVAERQQEY | 3631 | Q03001 | |
| QEEYEKQLRDNDETK | 806 | Q96MR6 | |
| LLKEDVQDYSEDLQE | 571 | O95202 | |
| ELEEANAKIQADIDY | 251 | Q5BJE1 | |
| CDLLREQYEEEQESK | 1346 | Q9UKX2 | |
| EQYEEEQESKAELQR | 1351 | Q9UKX2 | |
| QYESIAAKNLQEAEE | 271 | P41219 | |
| KDEYDDLSDLTAAQQ | 136 | O00264 | |
| NRYETNEEDKTLQEI | 406 | Q8N4B4 | |
| QAEEEIDEIRKSYQE | 756 | Q5T1M5 | |
| TKQEAVVEEDYNENA | 66 | P82970 | |
| IDNDQSGYLDEEELK | 51 | P0CE71 | |
| AEYDDQTSQREKEDD | 131 | P00451 | |
| LLREQYEEEQEAKAE | 1346 | P12882 | |
| SVEDNYIVLNKDDNE | 166 | P06213 | |
| DYDQALADIRENEQS | 936 | P52701 | |
| ELKEYENIIALQENE | 346 | P80303 | |
| EDNEEEVVYSNKQSL | 986 | A8MWY0 | |
| EEEILIYINDHEDKN | 1401 | O75161 | |
| NANKNDDYDNEEILT | 451 | Q8N3R9 | |
| IDNDQSGYLDEEELK | 51 | P0CE72 | |
| DFDEKEYQELNELQK | 1466 | Q460N5 | |
| QQKITDEEELNDYKL | 211 | Q9BZJ0 | |
| EFEVNDLNYEDKLQE | 711 | Q14674 | |
| YVEEDLAQQDKDEII | 216 | B1AJZ9 | |
| YLENLAQENEEEDIT | 1921 | Q4G0P3 | |
| ALEEYENATKEENCN | 76 | A0AVF1 | |
| QKADEEAYEAEIQAE | 541 | Q9P2K1 | |
| DELQDVKEERSSYQD | 121 | Q6ZUS6 | |
| EAEKAQQSYERLDND | 146 | Q5T0N5 | |
| DSIDKCELQEENQYL | 896 | P49917 | |
| YQNIQNIDEDEDLEV | 206 | A1XBS5 | |
| RQYKEDESQSEEEND | 231 | Q8NHQ1 | |
| YQDIEKEVNNESGES | 121 | Q9NQS1 | |
| NEDELKQQEELIERY | 86 | Q8N4A0 | |
| QAEYLNQCLEEDKNE | 121 | Q9P0W0 | |
| QEAEEKALNEEKVAY | 316 | Q8IX06 | |
| EEANREIEKYNQELE | 1151 | Q5TEA3 | |
| EVDLKDYEDQQKQLE | 191 | P02671 | |
| RDEINDALINQKYDE | 346 | Q9P0L2 | |
| EDENYENDSVRQLEN | 706 | Q9Y4J8 | |
| DEFYIELDQQLNDLE | 106 | P32881 | |
| KADYQAVDDEIEANL | 506 | P17655 | |
| EYDEEEEKNQLEIER | 86 | Q15020 | |
| KDDQLNKETEDYLNS | 536 | Q6PJW8 | |
| LKDTEDSLSYEDNQD | 556 | Q6PJW8 | |
| TYQNTDLSEIKEEEQ | 596 | Q32MZ4 | |
| QAKQNLYDLDEDDDG | 176 | Q9BY77 | |
| TLDINERQEQEDYQE | 1216 | Q9HAU5 | |
| EQLDDYNAKLSDLQE | 476 | Q16363 | |
| QTIDEEYDSIKNNIE | 286 | Q96QE2 | |
| EYDSIKNNIEEEEKE | 291 | Q96QE2 | |
| DLEEDDQEVLKDQNY | 56 | Q13416 | |
| YLEFEEEENKQLADS | 271 | Q92990 | |
| NEEENENSISQYKES | 301 | P82673 | |
| EALNYKFNDQDIEEI | 481 | Q92541 | |
| LNTKENLNDVDYDDV | 1101 | Q5VT97 | |
| KQLENLEQQKYDDED | 316 | Q9UI12 | |
| LEQQKYDDEDISEDI | 321 | Q9UI12 | |
| QAYENQEQLKDDDSD | 576 | Q92581 | |
| LNTIQIKYLDEENEE | 41 | Q14596 | |
| EDEDQLDEVVKYLQE | 601 | Q5H9M0 | |
| LDSEYNEELNEDDSQ | 1091 | P35251 | |
| KYENNVIQRTEDLED | 1386 | Q9Y2K3 | |
| EENEAIDQDLQAYIL | 601 | Q9HCD6 | |
| SKNEEKEEDDAENYR | 331 | Q8WVM0 | |
| LLREQYEEEQEAKAE | 1346 | Q9Y623 | |
| AYEEQNQATLEEAEQ | 426 | Q9NY46 | |
| REQYEEETEAKAELQ | 1346 | P13533 | |
| YEEQNQATLEEAEQK | 426 | P35498 | |
| IEERYEVSKSENENQ | 406 | Q96JJ7 | |
| DENNRYQVELENLKD | 861 | P82094 | |
| EQFDLAQYEEQDDIK | 1486 | Q13009 | |
| AQYEEQDDIKETDIL | 1491 | Q13009 | |
| YLEQLRQQEEEKAEA | 86 | O43818 | |
| QELETLKDLYNQDDN | 611 | Q9H269 | |
| LLREQYEEEQEAKAE | 1346 | Q9UKX3 | |
| QDVEKATNEYNTTED | 11 | O75886 | |
| RSKDEEADNDNYEVL | 131 | Q4J6C6 | |
| QEATAEQENKRYENE | 176 | Q9BT92 | |
| EEDKKINEELESQYQ | 71 | O00193 | |
| DLEINSVNSKYEDEQ | 276 | Q9H6N6 | |
| DQEDYKNRTQAVEEL | 361 | Q9Y4F4 | |
| EEFEKLLHQEEDNYN | 2301 | O15050 | |
| QAEAYNLDKVLDEFE | 6 | O95405 | |
| DENYLDRLAEEVNDK | 116 | O94874 | |
| EDNEVSSGLKQNYDE | 951 | Q14789 | |
| TYDQAKDLFNQEDEE | 486 | Q96M32 | |
| DDLYQQKIKEAEEED | 511 | O14777 | |
| QKDDIQIRFYEEEEN | 276 | P19838 |